Global Imc LLC’s Trillium Therapeutics Inc Position
Does Global Imc LLC own Trillium Therapeutics Inc (TREUR)? Not currently — the last reported position was 259.5K shares worth $4M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q3 2020
Shares
259.5K
% of Portfolio
+1.35%
Quarters Held
1
position exited
Position History TREUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2020 | 259.5K | $4M | +1.35% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of TREUR.